Gerald E Quirk Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gerald E Quirk.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gerald E Quirk. Gerald E Quirk is a See Remarks in INFINITY PHARMACEUTICALS, INC. ($INFI) and a VP,Cor. Affairs & Gnrl Counsel in INFINITY PHARMACEUTICALS, INC. ($INFI) and an General Counsel, Executive VP in Tokai Pharmaceuticals Inc ($TKAI) and a Chief Legal Officer in Syros Pharmaceuticals, Inc. ($SYRS).
Address: C/O INFINITY PHARMACEUTICALS, INC. 780 MEMORIAL DRIVE CAMBRIDGE 02139 MA
Companies in which Gerald E Quirk is an Insider
Eledon Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gerald E Quirk: General Counsel, Executive VP
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 17 2015
$ELDN Market Capitalization: $20.25M
$ELDN Previous Close: $0.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INFINITY PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gerald E Quirk: See Remarks, VP,Cor. Affairs & Gnrl Counsel
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 09 2012
$INFI Market Capitalization: $115.87M
$INFI Previous Close: $2.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syros Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gerald E Quirk: Chief Legal Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 21 2018
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Gerald E Quirk
Sentiment: All, ELDN, INFI, SYRS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21 2018 | SYRS | Syros Pharmaceutic ... | Quirk Gerald E | Chief Legal Officer | Option Exercise | A | 13.30 | 11,666 | 155,158 | 11,666 | |
| Feb 21 2018 | SYRS | Syros Pharmaceutic ... | Quirk Gerald E | Chief Legal Officer | Option Exercise | A | 10.09 | 75,000 | 756,750 | 75,000 | |
| Feb 13 2017 | SYRS | Syros Pharmaceutic ... | Quirk Gerald E | Chief Legal Officer | Option Exercise | A | 10.90 | 40,000 | 436,000 | 40,000 | |
| Sep 29 2016 | SYRS | Syros Pharmaceutic ... | Quirk Gerald E | Chief Legal Officer | Option Exercise | A | 13.30 | 105,000 | 1,396,500 | 105,000 | |
| Dec 17 2015 | TKAI | Tokai Pharmaceutic ... | Quirk Gerald E | General Counsel, Ex ... | Option Exercise | A | 9.65 | 62,000 | 598,300 | 62,000 | |
| May 28 2015 | TKAI | Tokai Pharmaceutic ... | Quirk Gerald E | General Counsel, Ex ... | Option Exercise | A | 10.81 | 214,605 | 2,319,880 | 214,605 | |
| Jan 09 2012 | INFI | INFINITY PHARMACEU ... | Quirk Gerald E | See Remarks | Option Exercise | A | 7.93 | 40,000 | 317,200 | 40,000 |